Patents by Inventor Nobuyuki Kibushi

Nobuyuki Kibushi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 21-Substituted steroid compound
    Patent number: 5945404
    Abstract: A glycoside represented by formula (I), wherein dexamethasone or betamethasone is the aglycon and the 21-position is substituted by a simple sugar or an acylated sugar selected from the group consisting of glucose, galactose, mannose, rhamnose, fucose, N-acetylglucosamine, N-acetylgalactosamine, galacturonic acid, glucuronic acid and sialic acid.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: August 31, 1999
    Assignee: Nissin Shokuhin Kabushiki Kaisha
    Inventors: Kei Sugai, Motoaki Goto, Satoshi Yoshida, Yumiko Noda, Takayuki Ishii, Nobuyuki Kibushi, Hutoshi Nishikawa
  • Method for modulating the immune system
    Patent number: 5763420
    Abstract: An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts, thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: June 9, 1998
    Assignee: MECT Corporation
    Inventors: Ryoichi Osawa, Isao Suda, Masaaki Numata, Mamoru Sugimoto, Kenkichi Tomita, Nobuyuki Kibushi, Takayuki Ishii, Naokazu Sugiyama, Makiko Kasano, Tae Yasunaga, Makoto Tanaka, Tomoya Ogawa, Mariko Ishii
  • Methods for inhibiting the chemotaxis of neutrophils
    Patent number: 5668115
    Abstract: An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: September 16, 1997
    Assignee: MECT Corporation
    Inventors: Ryoichi Osawa, Isao Suda, Masaaki Numata, Mamoru Sugimoto, Kenkichi Tomita, Nobuyuki Kibushi, Takayuki Ishii, Naokazu Sugiyama, Makiko Kasano, Tae Yasunaga, Makoto Tanaka, Tomoya Ogawa, Mariko Ishii
  • Anti-inflammatory agent
    Patent number: 5516764
    Abstract: An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.
    Type: Grant
    Filed: March 28, 1994
    Date of Patent: May 14, 1996
    Assignee: Mect Corporation
    Inventors: Ryoichi Osawa, Isao Suda, Masaaki Numata, Mamoru Sugimoto, Kenkichi Tomita, Nobuyuki Kibushi, Takayuki Ishii, Naokazu Sugiyama, Makiko Kasano, Tae Yasunaga, Makoto Tanaka, Tomoya Ogawa, Mariko Ishii